BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27620946)

  • 1. Using a symptom-specific instrument to measure patient-reported daily functioning in patients with cancer.
    Shi Q; Mendoza TR; Wang XS; Cleeland CS
    Eur J Cancer; 2016 Nov; 67():83-90. PubMed ID: 27620946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The European Organization for Research and Treatment of Cancer QLQ-C30: an examination into the cultural validity and reliability of the Turkish version of the EORTC QLQ-C30.
    Guzelant A; Goksel T; Ozkok S; Tasbakan S; Aysan T; Bottomley A
    Eur J Cancer Care (Engl); 2004 May; 13(2):135-44. PubMed ID: 15115469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychometric properties and measurement equivalence of the Multidimensional Fatigue Syndrome Inventory- Short Form (MFSI-SF) amongst breast cancer and lymphoma patients in Singapore.
    Chan A; Lew C; Wang XJ; Ng T; Chae JW; Yeo HL; Shwe M; Gan YX
    Health Qual Life Outcomes; 2018 Jan; 16(1):20. PubMed ID: 29351803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of a Patient-Reported Symptom and Functioning Assessment Tool for Geriatric Oncology Care in China.
    Xue D; Li P; Chen TH; Shi Q; Wang XS
    Value Health Reg Issues; 2022 May; 29():28-35. PubMed ID: 34801883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the reliability and validity of the EORTC QLQ-C30 in Turkish cancer patients.
    Cankurtaran ES; Ozalp E; Soygur H; Ozer S; Akbiyik DI; Bottomley A
    Eur J Cancer Care (Engl); 2008 Jan; 17(1):98-104. PubMed ID: 18181898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linguistic Validation of the M. D. Anderson Symptom Inventory in Persian-Speaking Iranian Cancer Patients.
    Saadatpour L; Hemati S; Habibi F; Behzadi E; Hashemi-Jazi MS; Kheirabadi G; Mirbagher L; Gholamrezaei A
    J Pain Symptom Manage; 2015 Sep; 50(3):387-393.e1. PubMed ID: 25980966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the M. D. Anderson Symptom Inventory multiple myeloma module.
    Jones D; Vichaya EG; Wang XS; Williams LA; Shah ND; Thomas SK; Johnson VE; Champlin RE; Cleeland CS; Mendoza TR
    J Hematol Oncol; 2013 Feb; 6():13. PubMed ID: 23384030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validity and reliability of the Swedish version of the Memorial Symptom Assessment Scale (MSAS): an instrument for the evaluation of symptom prevalence, characteristics, and distress.
    Browall M; Kenne Sarenmalm E; Nasic S; Wengström Y; Gaston-Johansson F
    J Pain Symptom Manage; 2013 Jul; 46(1):131-41. PubMed ID: 23195392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-related symptom assessment in France: validation of the French M. D. Anderson Symptom Inventory.
    Guirimand F; Buyck JF; Lauwers-Allot E; Revnik J; Kerguen T; Aegerter P; Brasseur L; Cleeland CS
    J Pain Symptom Manage; 2010 Apr; 39(4):721-33. PubMed ID: 20413059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The assessment of health-related quality of life and related factors in Chinese elderly patients undergoing chemotherapy for advanced cancer: a cross-sectional study.
    Li Q; Lin Y; Qiu Y; Gao B; Xu Y
    Eur J Oncol Nurs; 2014 Aug; 18(4):425-35. PubMed ID: 24721179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of two quality-of-life instruments for cancer patients: the functional assessment of cancer therapy-general and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30.
    Kemmler G; Holzner B; Kopp M; Dünser M; Margreiter R; Greil R; Sperner-Unterweger B
    J Clin Oncol; 1999 Sep; 17(9):2932-40. PubMed ID: 10561373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation study of the Korean version of the M. D. Anderson Symptom Inventory.
    Yun YH; Mendoza TR; Kang IO; You CH; Roh JW; Lee CG; Lee WS; Lee KS; Bang SM; Park SM; Cleeland CS; Wang XS
    J Pain Symptom Manage; 2006 Apr; 31(4):345-52. PubMed ID: 16632082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a disease-specific quality of life questionnaire (EQOL) for potentially curable patients with carcinoma of the esophagus.
    Clifton JC; Finley RJ; Gelfand G; Graham AJ; Inculet R; Malthaner R; Tan L; Lim J; Singer J; Lovato C
    Dis Esophagus; 2007; 20(3):191-201. PubMed ID: 17509114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Cross-sectional Study on the Symptom Burden of Patients With Spinal Tumor: Validation of the Chinese Version of the M.D. Anderson Symptom Inventory-Spine Tumor Module.
    Xu N; Li Z; Wei F; Liu X; Jiang L; Meng N; Jiang P; Yu M; Wu F; Dang L; Zhou H; Li Y; Liu Z
    J Pain Symptom Manage; 2017 Mar; 53(3):605-613. PubMed ID: 28042067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
    Park KU
    Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing health-related quality of life in gynecologic oncology: a systematic review of questionnaires and their ability to detect clinically important differences and change.
    Luckett T; King M; Butow P; Friedlander M; Paris T
    Int J Gynecol Cancer; 2010 May; 20(4):664-84. PubMed ID: 20442592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation and Application of the MD Anderson Symptom Inventory for Traditional Chinese Medicine (MDASI-TCM).
    Li Z; Shi Q; Liu M; Jia L; He B; Yang Y; Liu J; Lin H; Lin HK; Li P; Wang XS
    J Natl Cancer Inst Monogr; 2017 Nov; 2017(52):. PubMed ID: 29140491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life measures (EORTC QLQ-C30 and SF-36) as predictors of survival in palliative colorectal and lung cancer patients.
    Grande GE; Farquhar MC; Barclay SI; Todd CJ
    Palliat Support Care; 2009 Sep; 7(3):289-97. PubMed ID: 19788770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation and comparison of the health-related quality-of-life instruments EORTC QLQ-C30 and SF-36 in assessment of patients with chronic nonmalignant pain.
    Fredheim OM; Borchgrevink PC; Saltnes T; Kaasa S
    J Pain Symptom Manage; 2007 Dec; 34(6):657-65. PubMed ID: 17618079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CARES-SF used for prospective assessment of health-related quality of life after stem cell transplantation.
    Hjermstad MJ; Evensen SA; Kvaløy SO; Loge JH; Fayers PM; Kaasa S
    Psychooncology; 2003 Dec; 12(8):803-13. PubMed ID: 14681953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.